MARATTO

article · JAC-Antimicrobial Resistance

Drug-resistant tuberculosis treatment success predictors in Namibia

20241 citationOpen accessUniversity of Namibia

Abstract

Whilst DR-TB TSRs improved, they are below the global target and vary by clinical and patient demographics. Targeted interventions for high-risk patients, including female patients, those aged under 15 years, locals and those with bilateral pulmonary disease using community-based approaches to boost adherence, alongside leveraging the skills of clinical pharmacists, should now be explored.

Research topics

  • Tuberculosis Research and Epidemiology
  • Pneumonia and Respiratory Infections
  • HIV/AIDS Impact and Responses

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/jacamr/dlae211

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.